Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis

Phase 4 Terminated NCT02921555

Summary

The purpose of this study is to determine the efficacy of high-dose corticosteroid pulses added to conventional oral corticosteroid course for moderate flares of ulcerative colitis.

Percentage of Participants With Endoscopic and Clincal Remission

Change from baseline at week 8 · participants

Percentage of Participants With Endoscopic and Clinical Remission

Change from baseline at week 54 · Percentage of participants

Open in BENITIONS View on ClinicalTrials.gov

Other trials for this condition

• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Coliti — Janssen Research & Development, LLC
• GI Permeability Change in Response to Aquamin® — James Varani
• A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Seve — Hoffmann-La Roche
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerativ — Janssen Research & Development, LLC
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Mode — Janssen Research & Development, LLC
• Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Tre — First Affiliated Hospital of Kunming Medical University

All trials